All Highlights Obesity Addiction Stress/Anxiety/Depression Reviews Patents/Chapters
Converging vulnerability factors for compulsive food and drug use
Neuropharmacology. 2021 Sep. doi: 10.1016/j.neuropharm.2021.108556
Serafine, K. M., O'Dell, L. E., Zorrilla, E. P.
[ABSTRACT] [PUBLISHER LINK]
Corticotropin-releasing factor (CRF) and addictive behaviors
Int Rev Neurobiol. 2017 Aug. doi: 10.1016/bs.irn.2017.06.004
Roberto, M., Spierling, S. R., Kirson, D., Zorrilla, E. P.
[ABSTRACT] [PUBLISHER LINK]
Don't stress about CRF: assessing the translational failures of CRF1 antagonists
Psychopharmacology (Berl). 2017 May. doi: 10.1007/s00213-017-4556-2
Spierling, S. R., Zorrilla, E. P.
[ABSTRACT] [PUBLISHER LINK]
Stress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder
Neuropharmacology 62, 552-564, (2012)
Logrip, M. L., Zorrilla, E. P., Koob, G. F.
[ABSTRACT] [PUBLISHER LINK] [PUBMED CENTRAL]
Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view
Neuropsychopharmacology 37, 308-309, (2012)
Koob, G. F., Zorrilla, E. P.
[ABSTRACT] [PUBLISHER LINK]
The dark side of food addiction
Physiol Behav 104, 149-156, (2011)
Parylak, S. L., Koob, G. F., Zorrilla, E. P.
[ABSTRACT] [PUBLISHER LINK] [PUBMED CENTRAL]
Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention
CNS Drugs 25, 271-287, (2011)
Logrip, M. L., Koob, G. F., Zorrilla, E. P.
[ABSTRACT] [PUBLISHER LINK]
Progress in corticotropin-releasing factor-1 antagonist development
Drug Discov Today 15, 371-383, (2010)
Zorrilla, E. P., Koob, G. F.
[ABSTRACT] [PUBLISHER LINK] [PUBMED CENTRAL]
Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin
Brain Res 1314, 145-161, (2010)
Martin-Fardon, R., Zorrilla, E. P., Ciccocioppo, R., Weiss, F.
[ABSTRACT] [PUBLISHER LINK] [PUBMED CENTRAL]
Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor
Curr Opin Investig Drugs 11, 63-71, (2010)
Koob, G. F., Zorrilla, E. P.
[ABSTRACT] [PUBMED CENTRAL]
Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance
Swiss Med Wkly 138, 665-673, (2008)
Osborn, O., Gram, H., Zorrilla, E. P., Conti, B., Bartfai, T.
[ABSTRACT] [PUBLISHER LINK]
Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs
Front Neuroendocrinol 28, 1-27, (2007)
Fekete, E. M., Zorrilla, E. P.
[ABSTRACT] [PUBLISHER LINK] [PUBMED CENTRAL]
Homeostasis within the corticotropin-releasing factor system via CRF2 receptor activation: a novel approach for the treatment of anxiety
Drug Development Research 65, 205-215, (2005)
Valdez, G. R., Zorrilla, E. P., Koob, G. F.
[PUBLISHER LINK]
The therapeutic potential of CRF1 antagonists for anxiety
Expert Opin Investig Drugs 13, 799-828, (2004)
Zorrilla, E. P., Koob, G. F.
[ABSTRACT] [PUBLISHER LINK] [REQUEST PDF]
Nibbling at CRF receptor control of feeding and gastrocolonic motility
Trends Pharmacol Sci 24, 421-427, (2003)
Zorrilla, E. P., Tache, Y., Koob, G. F.
[ABSTRACT] [PUBLISHER LINK]
The relationship of depression and stressors to immunological assays: a meta-analytic review
Brain Behav Immun 15, 199-226, (2001)
Zorrilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., Schmidt, K.
[ABSTRACT] [PUBLISHER LINK] [REQUEST PDF]
Multiparous species present problems (and possibilities) to developmentalists
Dev Psychobiol 30, 141-150, (1997)
Zorrilla, E. P.
[ABSTRACT] [PUBLISHER LINK] [REQUEST PDF]
Relation of stressors and depressive symptoms to clinical progression of viral illness
Am J Psychiatry 153, 626-635, (1996)
Zorrilla, E. P., McKay, J. R., Luborsky, L., Schmidt, K.
[ABSTRACT] [PUBLISHER LINK] [REQUEST PDF]